The Central Research institute of Unani Medicine (CRIUM), Hyderabad- a decentralized institute functioning under the Central Council for Research in Unani Medicine (CCRUM), Department of Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homoeopathy (AYUSH), Ministry of Health and Family Welfare, Government of India. It was established in December, 1971 under the erstwhile Central Council for Research Indian Medicine and Homeopathy (CCRIMH), which was set up in 1969.
The U.S. Food and Drug Administration approved Genvoya (a fixed-dose combination tablet containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) as a complete regimen for the treatment of HIV-1 infection in adults and pediatric patients 12 years of age and older. Genvoya is marketed by Gilead Sciences Inc.